Tamoxifen Dose Adjustment on Indonesian Female ER+ Breast Cancer Patients Based on CYP2D6 Genotype and Endoxifen Levels
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: ER+ Breast Cancer
Interventions: DRUG: Tamoxifen dose adjustment
Sponsor: Nalagenetics Pte Ltd